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We propose a kinetic model for the self-aggregation by amyloid proteins. By extending several
well-known models for protein aggregation, the time evolution of aggregate concentrations containing
𝑟 proteins, denoted 𝑐𝑟(𝑡), can be written in terms of generalized Smoluchowski kinetics. With this
approach we take into account all possible aggregation and fragmentation reactions involving clusters
of any size. Correspondingly, an aggregate of size x+y could be formed by or break-up into two
smaller constituent aggregates of sizes x and y. The rates of each aggregation or fragmentation
reaction, called kernels, are specified in terms of the aggregate size, and we solve 𝑐𝑟(𝑡) for large cluster
sizes using numerical techniques. We show that by using Smoluchowski kinetics many pathways
to fibrillation are possible and quantities, such as the aggregate length distribution at an arbitrary
time, can be calculated. We show that the predicted results of the model are in agreement with the
experimental observations.
Keywords: protein aggregation, aggregation and fragmentation rates, conformational change, kinetics, length
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I. INTRODUCTION
Many experimental techniques have been developed to
study and characterize the kinetic processes involved in the
self-assembly of amyloid proteins into fibrils. The results
of experiments involving amyloid formation in vitro have
been used to formulate hypotheses about the pathological
process, and treatment of diseases caused by amyloid pro-
teins [1–10]. However, experiments often report different
results, especially during the early times in the aggregation
process, before 𝛽-amyloid fibrils have formed. As a result,
two competing hypotheses attempt to explain the results:
the nucleated polymerization mechanism (NP), and the nu-
cleated conformational conversion mechanism (NCC).
Protein aggregation can be monitored by ThT or Congo
Red dye, which may bind to aggregates that contain some
amount of 𝛽-sheet content, mainly fibrils [11–16]. Thus,
these dyes do not bind to oligomers that lack significant 𝛽-
sheet content [17, 18]. In experiments, the concentration of
monomers when fibrils may form is referred to as the critical
fibril concentration (CFC). The NP model contains several
essential features: (1) the lag-time exists for a nucleus to
form, and the concentrations of oligomers smaller than the
nucleus are assumed to be negligible, (2) the concentration
of amyloid protein monomers must exceed the critical fibril
concentration for fibrils to form, and (3) the lag-time de-
pends strongly on the initial amount of protein concentration
present [19, 20]. The equation for this relationship can be
written as [20]
ln 𝑡𝑙𝑎𝑔 = 𝐴−
(︂
𝑛𝑐 + 1
2
)︂
ln𝑚𝑡𝑜𝑡 (1)
where 𝐴 is a constant, and 𝑚𝑡𝑜𝑡 is the initial mass concen-
tration of amyloid protein monomers.
In contrast to the NP model, however, a variety of experi-
ments [21–27] provide evidence for non-vanishing oligomer
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concentrations when the monomer concentration is below
the CFC. These results led researchers to propose the NCC
mechanism [1], wherein quickly-forming oligomers undergo a
slow conformational transition from a largely unstructured
aggregate to a more organized nucleus that can grow into a
𝛽-sheet dominated fibril [1, 24, 27]. The same mechanism
for nucleus formation has been proposed for other amyloid
proteins including prions [1], A𝛽(1-40) [27], Huntington pro-
tein [28], and islet amyloid polypeptide [29]. Lee, et al. [27]
has even recently suggested the NP mechanism ought to be
abandoned for A𝛽(1-40) in favor of the NCC mechanism.
Since there may be major structural differences between the
unstructured oligomers and the highly-ordered fibrils, some
researchers have suggested that the early-time oligomers may
resemble micelles, when the concentration of free monomers is
above the critical micellar concentration (CMC) [21, 30, 31].
Thus, the process is characterized by a free-energy barrier
separating unstructured oligomers, such as micelles, and
structured fibril regimes [24, 27].
Adding to these complications are the large number of
possible aggregation and fragmentation reactions that de-
termine whether fibrils grow longer, or whether they break
up into smaller aggregates. For example, experiments and
simulations have shown that the pathways to fibrils could
be sequence dependent [32, 33], and merging between aggre-
gates of various sizes may play a role in the overall growth of
fibrils. Kinetics models for amyloid formation often assume
that the rates of elongation and fragmentation of aggregates
have no size dependency, and are unrelated to any other
properties that the amyloid proteins or aggregates may pos-
sess [19, 34–37]. The values of rate constants describing
aggregation or fragmentation determine not only the mass
of protein in fibrils as a function of time, but also the av-
erage lengths of the fibrils in time, two quantities that are
readily measured in experiments [38–41]. In other words,
understanding which aggregation or fragmentation reactions
contribute to the growth or shrinkage of fibrils, respectively,
is necessary for accurately predicting quantities such as the
total mass of protein in fibrils, the average lengths, and the
size distributions of fibrils as a function of time.
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2In the sections to follow, our aim is to introduce a kinetic
model for amyloidogensis in which nuclei may form and
undergo conformational transitions, where aggregates smaller
than the critical size may exist in non-zero concentrations,
and the length distributions of fibrils are accurately predicted.
In Section “Aggregate Systems Studied”, we consider in our
description of fibril formation a variety of fibril elongation
and fragmentation mechanisms, and then in Section “Size-
Dependent Kernels”, we show that the rates for aggregation
or fragmentation steps should in general depend on the
size of the aggregates. In Section “Results”, the model
predictions are compared with ThT and AFM experiments.
Finally, in Section “Generalized Kinetics”, we extend the
kinetics approach introduced initially to include the kinetics
of oligomers.
II. AGGREGATE SYSTEMS STUDIED
We consider a system containing a fixed initial concen-
tration of monomeric amyloid proteins, 𝑚𝑡𝑜𝑡, that are well
mixed with solvent. The proteins are freely mobile in the
solution and the system has a fixed volume, 𝑉 . According
to the law of mass-action, the reaction rate for reactions
between any protein monomers or aggregates are propor-
tional to the product of the reactant concentrations. In this
mean-field description, we consider the possible aggregation
pathways, from dimers, trimers, . . . , oligomers, . . . , proto-
fibrils, up through fibrils. A monomer is defined as a protein
that may or may not have a well-defined conformation, and
can interact with surrounding solvent. However, we consider
only interactions between proteins that may be responsible
for the formation, elongation, or breaking of aggregates. An
𝑁 -mer is an aggregate containing 𝑁 monomers, which could
range in size from dimers up to fibrils. Each monomer in an
aggregate may interact with other neighboring proteins in
the same aggregate via hydrophobic interactions or hydrogen
bonds.
A. Critical nuclei
As we have discussed, there is much debate as to whether
amyloid fibrils nucleate directly from protein solution, or
whether oligomers form first and then convert into fibrils
(or perhaps both processes are occurring simultaneously).
It is commonly assumed in the NP kinetic models that the
concentrations of aggregates that are smaller than the critical
nucleus are negligible, and the critical nucleus represents the
aggregate with the highest energy along the pathway. Since
the NP and NCC mechanisms could be two extremes of some
underlying nucleation mechanisms [27, 42], we consider when
a NCC model may become ‘NP-like’, that is, it contains the
feature that the concentration of nuclei is proportional to the
monomer concentration raised to the 𝑛𝑐 power, as in the NP
models of Oosawa-Kasai and Knowles, et al., [36] discussed
below. The validity of the models discussed here are based
on comparing the model predictions with experimental data,
for example, data from ThT, AFM, and FlAsH fluorescence
experiments.
In this section, we consider a model in which a protein
can exist in two different conformations, that we shall call
A-type and B-type, respectively. The oligomers are assumed
to have appreciable concentrations only as A-type aggregates,
while the fibrils are of the B-type aggregates. The A-type
aggregates could, for instance, resemble micelles and have
a spherically symmetric shape [21, 30, 31]. In NP kinetic
models [19], the critical nucleus forms via the interactions of
𝑛𝑐 number of proteins according to the reaction
𝑛𝑐𝐶1
𝑘1

𝑘2
𝐶𝐴𝑛𝑐 (2)
where the concentrations of aggregates smaller than 𝑛𝑐 are
assumed zero, and 𝑘1 and 𝑘2 are the formation and dissocia-
tion rate constants of the nucleus in solution. Once nuclei
are formed, they may proceed to grow into fibrils. In our
formulation, we incorporate a conformational transition of
A-type to B-type aggregates of size 𝑛𝑐 as is illustrated in
Fig. 1, in accordance with a NCC mechanism. The reaction
for conformationally induced transitions of A-type to B-type
nuclei can be written as
𝐶𝐴𝑛𝑐
𝑘
′
𝑛

𝑘*
𝐶𝐵𝑛𝑐 (3)
where 𝑘
′
𝑛 and 𝑘
* are, respectively, the rate constants for 𝑛𝑐
number of proteins converting from conformation A to B,
and B to A reversibly [43]. As soon as B-type aggregates
form, they may grow into fibrils, where the fibril growth and
shrinkage pathways are discussed in the next section. The
rate of change of the B-type nuclei takes the form
𝑑𝑐𝐵𝑛𝑐(𝑡)
𝑑𝑡
= 𝑘
′
𝑛𝑐
𝐴
𝑛𝑐(𝑡)− 𝑘*𝑐𝐵𝑛𝑐(𝑡). (4)
In Eq. (4), there will also be the rates where 𝑐𝐵𝑛𝑐 is converted
to larger oligomers. These pathways are discussed in the
next section. If the A-type micelles form rapidly and convert
into B-types, the A-type oligomer phase can be effectively
by-passed [44]. The reactions in Eq. (2) are taken to be in
kinetic equilibrium, thus Eq. (4) can be written as
𝑑𝑐𝐵𝑛𝑐(𝑡)
𝑑𝑡
= 𝑘𝑛𝑐1(𝑡)
𝑛𝑐 − 𝑘*𝑐𝐵𝑛𝑐(𝑡) (5)
which is similar to the equation used by Oosawa and
Asakura [19], and others [36], for nuclei production of con-
stant size and we have defined 𝑘𝑛 ≡ 𝑘1𝑘′𝑛/𝑘2. In Section
“Generalized Kinetics” we will consider Eq. (4) for the case
when oligomers may reach metastable states instead of di-
rectly going to equilibrium, and can compare this approach
to the formation of fibrils with the FlAsH fluorescence exper-
iments carried out by Lee, et al. [27].
In the above treatment of the fibril nucleus, we assumed
that the initial monomeric protein solution was highly super-
saturated and that a pre-equilibrium between monomers in
solution and the fibril nucleus of size 𝑛𝑐 exists. However,
as more and more monomers join aggregates, the solution
3FIG. 1. (a) A small aggregate of size 𝑛𝑐 could undergo a conforma-
tional transition from a structured (blue) to an aggregate which
contains 𝛽-sheet (black). (b) The Becker-Do¨ring type kinetics
of monomer addition and subtraction pathways. (c) Illustrating
the Smoluchowski aggregation and fragmentation pathways. The
Becker-Do¨ring kinetics is a special case of Smoluchowski kinetics.
All illustrations are schematic; the aggregates in (c), for example,
could merge laterally.
eventually becomes only weakly super-saturated or saturated
so that new fibrils can only form from either the breaking
of larger aggregates or through nucleation events. In these
cases, the size of the fibril nucleus may not be constant or
correspond to a single 𝑛𝑐 value and Eq. (5) is not strictly jus-
tified. Furthermore, Kashchiev and co-workers have pointed
out that the fibril nucleation rates cannot be described by
Eq. (5), even if the nucleus size remained constant. These
points are well discussed in their recent paper [45]. We never-
theless use Eq. (5) because it is well known to reproduce the
scaling relation of Eq. (1) when comparing the model to ThT
experiments. In future studies of protein amyloid aggregates
involving mass-action equations, we hope to address the pe-
culiar problem of fibril nucleation more correctly. To begin,
we first focus on using the NP-like description to study how
fibrils may grow and shrink in size, which are compared with
ThT and AFM experiments. This is discussed in the next
section.
B. Fibril formation pathways
In their model for actin polymerization, Oosawa and
Asakura assumed the pathways for actin filaments to grow or
shrink in size are monomer addition and monomer subtrac-
tion, respectively [19]. These reactions are just two of the
many possible pathways for amyloid aggregate growth and
shrinkage. While it could be the case that these two reac-
tions dominate the changes in aggregate sizes, other types of
growth and fragmentation mechanisms may also contribute.
For example, Knowles et al. [36], and others [46] have showed
that strong fragmentation can act as an effective secondary
nucleation mechanism, whereby fragment aggregates can
act as seeds that speed up elongation of fibrils during early
times of aggregation. For the case of strong fragmentation,
𝑡1/2 ∼ 𝑚−1/2𝑡𝑜𝑡 , otherwise 𝑡1/2 ∼ 𝑚−(𝑛𝑐+1)/2𝑡𝑜𝑡 , which is the
prediction of the Oosawa-Asakura NP model.
By generalizing the Becker-Do¨ring approach, that is,
monomer addition and subtraction, all possible ways of form-
ing an aggregate containing 𝑟 proteins can be taken into
account [47]. In the most general case, any two fibrils of sizes
𝑟 and 𝑠 could merge to form a larger aggregate, which can be
described the rate constant 𝑎𝑟,𝑠. Alternatively, a fibril of size
𝑟+𝑠 could break into two pieces of sizes 𝑟 and 𝑠, respectively,
which can be described by the rate constant 𝑏𝑟+𝑠. Both of
these scenarios are illustrated in Fig. 1(c). The expression
for these types of reactions can be written as
𝐶𝑟 + 𝐶𝑠
𝑎𝑟,𝑠

𝑏𝑟+𝑠
𝐶𝑟+𝑠 (6)
and is referred to as generalized Smoluchowski kinetics [48,
49]. The aggregation and fragmentation rate constants 𝑎𝑟,𝑠
and 𝑏𝑟+𝑠, respectively, are referred to as kernels and must
be symmetric, that is 𝑎𝑟,𝑠 = 𝑎𝑠,𝑟 and 𝑏𝑟+𝑠 = 𝑏𝑠+𝑟. By
imposing the law of mass action, the mass flux from aggregate
concentrations 𝑐𝑟(𝑡) and 𝑐𝑠(𝑡) going to 𝑐𝑟+𝑠(𝑡) can be written
as
𝑊𝑟,𝑠(𝑡) = 𝑎𝑟,𝑠𝑐𝑟(𝑡)𝑐𝑠(𝑡)− 𝑏𝑟+𝑠𝑐𝑟+𝑠(𝑡) (7)
where the NP nucleation phenomena described by Eq. (4)
restricts 𝑐𝑟(𝑡) = 0 if 𝑟 < 𝑛𝑐 except for 𝑟 = 1. If 𝑛𝑐 ≥ 2,
𝑊1,1(𝑡) = 0. The corresponding mass-action equations for
the evolution of an aggregate of size 𝑟, where 𝑟 ≥ 𝑛𝑐, can be
written using Eq. (7) as
𝑑𝑐𝑟(𝑡)
𝑑𝑡
=
1
2
𝑟−1∑︁
𝑠=1
𝑊𝑠,𝑟−𝑠(𝑡)−
∞∑︁
𝑠=1
𝑊𝑟,𝑠(𝑡)
+ (𝑘𝑛𝑐1(𝑡)
𝑛𝑐 − 𝑘*𝑐𝑛𝑐(𝑡)) 𝛿𝑟,𝑛𝑐
(8)
where the first term in Eq. (8) counts every way to construct
the aggregate of size 𝑟 twice, hence the factor of one-half.
The first two terms describe all possible ways to for the
aggregate of size 𝑟 to form and to disintegrate. The rate
constants 𝑘𝑛 and 𝑘
* were defined above, and the Kronecker
delta equals one if 𝑟 = 𝑛𝑐, and zero otherwise. To reduce the
total number of parameters in Eq. (8), we assume oligomers
can only convert from A- to B-type, and that 𝑘* may be
set to zero. Knowles’ model combines monomer addition
and subtraction, with the fragmentation part of reactions of
the generalized Smoluchowski model [36, 50]. Since Knowles’
model is well-studied [51–53], we compare with it our results
obtained for the Smoluchowski model of protein aggregation.
The resulting equations for the evolution of cluster sizes 𝑐𝑟(𝑡)
in Knowles’ model are
𝑑𝑐𝑟(𝑡)
𝑑𝑡
= 2𝑘+𝑐1(𝑡) [𝑐𝑟−1(𝑡)− 𝑐𝑟(𝑡)]− 𝑘−(𝑟 − 1)𝑐𝑟(𝑡)
+ 2𝑘−
∞∑︁
𝑖=𝑟+1
𝑐𝑖(𝑡) + 𝑘𝑛𝑐1(𝑡)
𝑛𝑐𝛿𝑟,𝑛𝑐
(9)
where 𝑘+ is the monomer addition rate constant, 𝑘− is the
rate constant of any type of breaking up of an aggregate
4into two pieces, regardless of the sizes of the fragments, and
𝑘𝑛 describes the nucleus formation in Eq. (9). From the
conservation of mass condition, 𝑚𝑡𝑜𝑡 =
∑︀∞
𝑘=1 𝑘𝑐𝑘(𝑡), the
evolution of the monomer concentration, 𝑐1(𝑡), in Eqs. (8)
and (9) can be written as
𝑑𝑐1(𝑡)
𝑑𝑡
= −
∞∑︁
𝑗=𝑛𝑐
𝑗
𝑑𝑐𝑗(𝑡)
𝑑𝑡
. (10)
In Eqs. (8) and (9), assuming 𝑎𝑟,𝑠 = 𝑘+ and 𝑏𝑟+𝑠 = 𝑘− can
be a very useful approximation that make these equations
easier to solve, and also the number of parameters needed to
capture the aggregation and fragmentation processes can be
kept to a minimum. However, in reality the physics should
play a role in determining 𝑎𝑟,𝑠 and 𝑏𝑟+𝑠. The size, shape,
and even the conformation of monomers and aggregates, as
well as thermal breaking [54], may influence the rates. With
Becker-Do¨ring and Smoluchowski kinetics, we can consider
the long-time behavior of the aggregate concentrations, 𝑐𝑟(𝑡),
and derive expressions relating the fragmentation rates with
size-dependent aggregation rates. In the next section, we
show that once an aggregation kernel is determined, the
fragmentation kernel can also be determined, and Eq. (8) is
solvable for size dependent kernels.
III. SIZE-DEPENDENT KERNELS
Two asymptotic states of the system described by Eqs. (8)
and (9) are usually of interest:
1. The system reaches a steady state, when all the fluxes
are constant as defined in Eq. (7), all of the 𝑐𝑟(𝑡)’s do
not change in time, that is, 𝑊𝑟,𝑠(𝑡) = 𝑊 for all 𝑟 and
𝑠, where 𝑊 is a constant flux.
2. The system reaches equilibrium, where in Eq. (7) the
forward reaction exactly balances the backwards reac-
tion, i.e., 𝑊𝑟,𝑠(𝑡) = 0 for all 𝑟 and 𝑡.
We assume that our protein systems will eventually tend
toward thermodynamic equilibrium and invoke detailed bal-
ancing, i.e., case 2 above, where the Smoluchowski mass flux,
Eq. (7), equals zero for all 𝑟 and 𝑠. Thus, we may write
Eq. (7) as
𝑎𝑟,𝑠𝜌𝑟𝜌𝑠 = 𝑏𝑟+𝑠𝜌𝑟+𝑠 (11)
where 𝜌𝑖 is the equilibrium concentration for the aggregate
containing 𝑖 monomers and the equilibrium dissociation con-
stant 𝐾 = 𝜌𝑟𝜌𝑠/𝜌𝑟+𝑠 = 𝑏𝑟+𝑠/𝑎𝑟,𝑠. The equilibrium concen-
trations 𝜌𝑟 can be expressed as 𝜌𝑟 = 𝑍𝑟/𝑉 where 𝑍𝑟 is the
partition function of an aggregate of size 𝑟 [49, 55, 56] and 𝑉
is the volume of the system. Solving Eq. (11) for 𝑏𝑟+𝑠 yields
𝑏𝑟+𝑠 =
𝑍𝑟𝑍𝑠
𝑍𝑟+𝑠
𝑎𝑟,𝑠. (12)
As an example, 𝑍𝑁 for an 𝑁 -mer aggregate can be written
as [55]
𝑍𝑁 = 𝑍𝑡𝑟𝑎𝑛𝑠𝑄𝑖𝑛 (13)
where 𝑍𝑡𝑟𝑎𝑛𝑠 is the contribution from translational motion
of the aggregate, and 𝑄𝑖𝑛 is the contribution due to internal
motion and interactions between proteins in the aggregate.
𝑄𝑖𝑛 contains the contributions from rotational degrees of
freedom for proteins in the aggregate, as well as collective
vibrations of the aggregate itself. If the aggregates are re-
garded as being linear chains, the contribution due to the
vibrations has a simple dependence on 𝑁 [55, 57–59] and
𝑍𝑁 can be written as [60]
𝑍𝑁 = 𝑋𝑞
𝑁𝑁𝑛𝑉 (14)
where 𝑋 is a composite factor, 𝑞𝑁𝑉 is the contribution of an
infinite aggregate, and 𝑋𝑁𝑛 takes into account the bound-
ary effects due to finitely-sized aggregates. The parameter
𝑛 depends on the exact description of the proteins in aggre-
gates as well as the collective properties and typically ranges
between 4 and 6 [60]. In this article, we assume 𝑛 = 4 in all
calculations. Plugging Eq. (14) into Eq. (12) and simplifying
yields
𝑏𝑟+𝑠 = 𝑋
(︂
𝑟𝑠
𝑟 + 𝑠
)︂𝑛
𝑎𝑟,𝑠 (15)
and only the problem of determining the aggregation kernel
𝑎𝑟,𝑠 is left.
A. Protein Diffusion
If the motions of monomers and aggregates in solvent are
assumed to be controlled by diffusion alone, results from coag-
ulation theory [61, 62] may be used to write the aggregation
rates as
𝑎𝑖,𝑗 ∝ (𝐷𝑖 + 𝐷𝑗) (𝑅𝑖 + 𝑅𝑗) (16)
where 𝐷𝑖 is the diffusion coefficient for a cluster of radius 𝑖,
and is equal to 𝐷𝑖 = 𝑘𝐵𝑇/6𝜋𝑖𝜂 where 𝜂 is the viscosity of
the solvent. 𝑅𝑖 is the radius of the sphere of influence of the
aggregate of radius 𝑖, which represents the maximum spatial
separation two aggregates could be from each other and still
stick together. In absence of understanding how the structure
of aggregates might relate to reactivity, Eq. (16) is simplified
and compared with previous studies [60] of aggregation and
fragmentation of linear aggregates by assuming that 𝑅𝑖 is
on the order of the aggregate’s hydrodynamic radius [61]. A
simplified expression for 𝑎𝑖,𝑗 can be re-expressed in terms of
𝑟, the number of proteins in the aggregate, and the fractal
dimension of the aggregate, 𝐷𝑓 , as [63, 64]
𝑎𝑟,𝑠 = 𝑘𝑃
(︁
𝑟−1/𝐷𝑓 + 𝑠−1/𝐷𝑓
)︁
(17)
where 𝑘𝑃 is a composite factor. The fractal dimension can be
thought of as a measure of the compactness of the aggregate.
For spherical monomers and aggregates 𝐷𝑓 = 3. This value
would probably be an oversimplification in our model because
fibrils are not spherical entities, rather they are linear, non-
branching structures. A value of 𝐷𝑓 ≈ 2.56 has been found
for antibody aggregates [63, 64]. It is important to note
5FIG. 2. Illustrating Eq. (17) in (a), and Eq. (18) in (b). In both
cases the kernels were normalized for illustrative purposes. The
plots show that both kernels exhibit symmetry in indices 𝑟 and
𝑠. In (b), the cut off size for aggregates was set to 100, meaning
𝑟 + 𝑠 ≤ 100. Additionally 𝐷𝑓 = 3 was used in Eqs. (17) and (18).
that many different forms of kernels have been used in the
literature for studying protein aggregation [57, 60–62, 65–70],
and that other kernels may also be valid for various kinetics
scenarios. From Eqs. (15) and (17), the fragmentation kernel
can be written as
𝑏𝑟+𝑠 = 𝑘𝑀
(︂
𝑟𝑠
𝑟 + 𝑠
)︂𝑛 (︁
𝑟−1/𝐷𝑓 + 𝑠−1/𝐷𝑓
)︁
, (18)
where 𝑘𝑀 is also a composite factor. In the next section,
we use 𝑘𝑃 , 𝑘𝑀 , 𝑘𝑛, and 𝐷𝑓 as adjustable parameters when
comparing with experiments.
The aggregation kernel, Eq. (17), is plotted in Fig. 2(a).
As illustrated, monomer addition is predicted to be the
favored pathway for small aggregates to grow larger, but
this elongation mechanism weakens as the system size grows
larger. Additionally, the aggregation kernel describes the
merging of any two aggregates, where smaller aggregates
are more likely to merge with larger ones than larger with
larger. When aggregates grow large in size, the overall effect
of merging on aggregate size progressively becomes weaker.
In Fig. 2(b), 𝑏𝑟+𝑠 appears Gaussian and reaches a maxi-
mum when both 𝑟 and 𝑠 reach one-half the cut-off size for a
finite system. The figure clearly shows that aggregates are
more likely to break in the middle, and they become even
more likely to break as overall aggregate sizes grow larger.
Monomer subtraction is the least likely scenario for aggre-
gate shrinkage. Additionally, increasing 𝑛 in Eq. (18) (not
shown) has the effect of reducing the overall ability of the
aggregate to break into any two pieces, while progressively
favoring breaking nearer to the center of the aggregate. Over-
all, the aggregation and fragmentation kernels yield similar
predictions as Hill’s studies of linear aggregates [60].
IV. RESULTS
In this section, Eqs. (8) and (9) are solved together with
Eq. (10) in each case, and some quantities that can be
compared with experiments are obtained. We first study
the constant kernel formulations for both the Knowles and
Smoluchowski models, then consider size-dependent kernels
given by Eqs. (17) and (18) for the Smoluchowski model.
In order to compare with experiments, the moment gen-
erating function, 𝑀𝑛(𝑡), for the set {𝑐𝑘(𝑡)}∞𝑘=1 is defined
as 𝑀𝑛(𝑡) ≡
∑︀∞
𝑘=𝑛𝑐
𝑘𝑛𝑐𝑘(𝑡) so that the number of proteins
in aggregates, 𝑃 (𝑡) = 𝑀0(𝑡), and the mass of aggregates,
𝑀(𝑡) = 𝑀1(𝑡), are given by
𝑃 (𝑡) =
∞∑︁
𝑘=𝑛𝑐
𝑐𝑘(𝑡) (19)
𝑀(𝑡) =
∞∑︁
𝑘=𝑛𝑐
𝑘𝑐𝑘(𝑡) (20)
and the average length of aggregates, 𝐿(𝑡), can be written as
𝐿(𝑡) =
𝑀(𝑡)
𝑃 (𝑡)
. (21)
Other quantities, such as the fluctuation in the number of
proteins in aggregates, are easily derived by using the moment
generating function 𝑀𝑛(𝑡).
Eq. (9) is often solved in terms of 𝑃 (𝑡) and 𝑀(𝑡), where in
some cases exact expressions are attainable. In our approach,
we solve the equations for aggregate concentrations described
by Eqs. (8) and (9) numerically. Numerical solutions require
that a cut-off size be introduced so that integration of the cou-
pled set of differential equations in both models is tractable.
Thus, in Knowles’ model and the Smoluchowski model, the
maximum size of an aggregate is denoted 𝜆𝑏. Conserving
mass requires us to truncate Eqs. (8) and (9) so that mass-loss
cannot occur, therefore we impose the following condition
to the set of concentrations {𝑐𝑘(𝑡)}∞𝑘=1 in each model for all
times: 𝑊𝑟,𝑠(𝑡) = 0 if 𝑟 + 𝑠 > 𝜆𝑏 in Eq. (8), and 𝑐𝑟(𝑡) = 0
if 𝑟 + 1 > 𝜆𝑏 in Eq. (9). Once the set of concentrations
{𝑐𝑘(𝑡)}∞𝑘=1 is computed, the mass and lengths of aggregates
can be calculated.
A. Constant kernel results
In Fig. 3, we fit the mass in fibrils, 𝑀(𝑡), to the 70𝜇M
ThT fluorescence data set for Curli fibrils by adjusting 𝑘+,
𝑘−, and 𝑘𝑛 in Eqs. (8) and (9) [71]. The fit parameters where
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FIG. 3. The mass in aggregates 𝑀(𝑡) in Knowles’ model (dashed
lines) is fitted to the results of Hammer et. al, for three different
initial mass concentrations, 𝑚𝑡𝑜𝑡, of CgsB: 70, 35, and 17.5 𝜇M
from top to bottom, respectively. 𝑀(𝑡) for the Smoluchowski
model is plotted (solid lines) and was fit to the same experimental
data. The parameters used in Knowles’ model were 𝑘+ = 2.65 ·104
M−1s−1, 𝑘− = 9 · 10−8 s−1. In the Smoluchowski model, the
parameters used were 𝑘+ = 5.3 · 104 M−1s−1, 𝑘− = 1.8 · 10−7 s−1.
In both models 𝑘𝑛 = 4.62 · 10−4 M−1s−1 was used. Experimental
data points are shown as red dots in the figure.
then used to predict 𝑀(𝑡) for the 35𝜇M and 17.5𝜇M data
sets. The fluorescence signal was scaled in accordance with
the initial amount of protein used. Additionally, the critical
nucleus size for Curli fibrils is regarded as 𝑛𝑐 = 2 [46, 71, 72].
Both the Smoluchowski and Knowles’ model fit the 70𝜇M
and 35𝜇M data sets quite well, but the fits are not as good
for the 17.5𝜇M data set. Overall, Knowles’ model has been
shown to reliably fit a variety of ThT data for many different
proteins [36, 46] with different critical nucleus sizes. However,
the Smoluchowski model has not been as extensively studied
for protein aggregation, except for a few cases [61, 64, 70].
It is not clear from the mass plots in Fig. 3 that there are
significant differences between the predictions of the Knowles
and Smoluchowski models. However, since the ThT signal
is proportional to the mass of protein in fibrils, and not the
fibril sizes, a flattening in the ThT signal does not imply the
fibrils have necessarily stopped growing longer or shorter. In
other words, just fitting the mass of fibrils, 𝑀(𝑡), to ThT
curves is not enough to establish which model, if any, is the
better model for protein aggregation. Thus, we turn our
attention to the time evolutions of the number of aggregates
and the aggregate average lengths. In Fig. 4, we plot the
total number of aggregates, 𝑃 (𝑡), for both Smoluchowski and
Knowles models using the fits of the ThT curves for Curli
fibrils. For all cases of initial mass concentration, the num-
ber of aggregates increases from zero and increases almost
linearly. The trend in Knowles’ model seems to be for higher
initial mass concentrations, more aggregates are present at
all times studied. The Smoluchowski model predicts signifi-
cantly different behavior. For smaller mass concentrations,
there are more aggregates present at early times, but as time
progresses, these roles seem to reverse: there are more aggre-
gates for higher initial mass concentrations when compared
to lower mass concentrations. Interestingly, as the initial
mass increases in the Smoluchowski model, the number of
aggregates, 𝑃 (𝑡), exhibits a sigmoidal-like curve, in contrast
to the effectively linear growth in the number of fibrils in
Knowles’ model at higher times. This seems to suggest that
the average lengths in the Smoluchowski model will converge
towards a constant value, whereas in Knowles’ model the av-
erage lengths will become shorter for the time scales studied
here.
To illustrate these effects, we plot in Fig. 4(c) and (d) the
average lengths of aggregates, 𝐿(𝑡), i.e. Eq. (21), for both
the Smoluchowski and Knowles’ model using the parameters
that best fit 𝑀(𝑡) to the Curli ThT data. The plots illustrate
the fact that in both models the higher the initial mass con-
centration, the longer the fibrils may initially grow. At some
time 𝑡 the average length of fibrils, 𝐿(𝑡), reaches a maximum
value, and then starts to decrease as time moves forward.
The curves are also more strongly peaked for greater initial
mass concentration, where the peak broadens and decreases
in maximum amplitude as the initial mass is decreased. For
all initial mass concentrations, 𝑚𝑡𝑜𝑡, considered in Knowles’
model, the average length of fibrils, 𝐿(𝑡), decreases to only
a fraction of its peak value as time progresses, eventually
trending toward a common constant value once the system
nears equilibrium. The peaks in the length curves must mean
that the aggregates initially are few and over-shoot a stable
average length, but as their numbers increase and monomers
become scarce, fragmentation becomes more important, and
their average lengths eventually approach a stable value near
equilibrium. However, for the Smoluchowski model, clearly
the effect of fragmentation is weakened at large times and the
average aggregate length of fibrils, 𝐿(𝑡), does not decrease as
significantly as in Knowles’ model . Additionally, the average
fibril lengths in the Smoluchowski model are longer than
in Knowles’ model, particularly at larger time scales. As is
known, the fragmentation reactions can speed up the forma-
tion of small aggregates in both models for early times, but
the possibility for aggregates of any size to merge into larger
ones in the Smoluchowski model seems to counter-balance the
breaking effect at greater times. To summarize, we observe
for large times, Knowles’ model predicts that more and more
aggregates will form, and the lengths of these aggregates get
shorter and shorter. However, in the Smoluchowski model,
the number of aggregates flattens out, as does the average
lengths of these aggregates.
For a better look at the predicted size distribution of the
Curli fibrils, a contour plot is presented in Fig. 5 where
each mass contribution 𝑟𝑐𝑟(𝑡) is plotted against 𝑟 and time
for both models using the initial concentration of 35𝜇M for
the Curli fibrils. In Fig. 5(a), the fibril mass, 𝑀(𝑡), for
Knowles’ model at early times is initially spread out over
many clusters sizes, but for longer times the overall fibril mass
contributions become highly clustered around the average
length value, ⟨𝐿⟩ ≈ 300, thus fluctuations about the average
length are relatively modest. In Fig. 5(b), the overall system
size in the Smoluchowski model is significantly larger than
for Knowles’ model, where at long times the fibril mass,
𝑀(𝑡), in the Smoluchowski model is spread out amongst
many cluster sizes, and that the fluctuation in mass (not
shown) is quite large when compared to Knowles’ model.
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FIG. 4. In (a) the number of aggregates 𝑃 (𝑡) for Knowles’ model is shown using the same fit parameters as in Fig. 3(a) for the
three different initial mass concentrations of CgsB: 70, 35, and 17.5 𝜇M from top to bottom, respectively. In (b) we plot 𝑃 (𝑡) for the
Smoluchowski model using the same fit parameters as in Fig. 3(b). In (c) the average length of fibrils, 𝐿(𝑡), is plotted for Knowles’
model, while in (d) 𝐿(𝑡) is plotted for the Smoluchowski model.
FIG. 5. The mass contributions 𝑟𝑐𝑟(𝑡) for 𝑟 and time for the Knowles (left) and Smoluchowski (right) models, respectively. In both
plots, the solid black curve represents the average length of fibrils, 𝐿(𝑡). The parameters used in Knowles’ and the Smoluchoswki
model were the same as those used in Fig. 3, and the initial mass concentration was 𝑚𝑡𝑜𝑡 = 35𝜇M.
Therefore, for the parameters used in the fit, fragmentation
in the Smoluchowski model does not play as a significant
role at later times as in Knowles’ model, and that many
cluster sizes contribute to the total fibril mass as compared
to Knowles’ model. The differences must attribute to the
possibility of aggregates of any size to merge. Since the size
of aggregates plays an important role in their toxicity, it
is important for the interpretation and treatment to know
which model, if any, describes the correct pathway. For
this analysis, size-dependent kernels become necessary since
the rates allow for determination of the properties of the
aggregates that can be measured. The question then is which
aggregation and fragmentation kernels should used in the
Smoluchowski kinetics predictions for the average lengths,
𝐿(𝑡).
B. Size-dependent kernel results
We now show that the size-dependent aggregation and
fragmentation kernels can be used to fit ThT and average
length data. The average length of 𝛽-lactoglobulin (𝛽-LAC)
fibrils at acidic pH were measured using an AFM at different
incubation times, where the initial mass of protein used
was 10 g/L and 𝑛𝑐 = 4 [41]. The experiment showed that,
starting from a monomeric solution, the proteins assembled
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FIG. 6. The comparison of 𝐿(𝑡) (left) to the experimentally determined average lengths of 𝛽-LAC fibrils. The data points are red dots.
𝑀(𝑡) (right) is plotted for the 𝛽-LAC fibrils. The fit parameters used for the black solid curve in both plots were 𝑘𝑃 = 4.71 ·102 M−1s−1,
𝑘𝑀 = 1.74 · 10−16 M−1 s−1, 𝑘𝑛 = 8.86 M−1 s−1, and 𝐷𝑓 = 1.34. For the dashed blue curves in both plots, the parameters used were
𝑘𝑃 = 8.16 · 102 s−1, 𝑘𝑀 = 1.15 · 10−16 M−1 s−1, 𝑘𝑛 = 1.8 M−1 s−1, and 𝐷𝑓 = 1.35. Additionally in both plots, 𝜆𝑏 = 8192 and 𝑛 = 4
was used in Eq. (18).
into fibrils and steadily grew longer until peaking at 1.6 𝜇m
in length at 8 hours. The fibrils then steadily declined in
length– the average length was about 0.8𝜇m at 20 hours.
After 20 hours it appeared that the fibrils were only slightly
shrinking in average length, though there were only a few
measurements made after 20 hours. The experimental results
for 𝐿(𝑡) for the 𝛽-LAC fibrils are plotted in Fig. 6. In order
to compare the model predictions of 𝐿(𝑡) with the AFM
results, the measured lengths must be converted to number of
proteins, 𝑟, in the fibrils. A simple conversion is 𝑟 = 2×𝐿/𝑑,
where 𝐿 is the measured value of 𝐿 in nanometers. For
A𝛽, 𝑑 ≈ 0.62nm [9, 41], here 𝑑 = 1.5 nm was used as a
rough estimate of the distance between to two neighboring
sheet-conformed 𝛽-LAC proteins in a fibril. This value of
𝑑 also helps facilitate shorter numerical computation times.
Additionally, the factor of two refers to the assumption that
two identical protofibrils that make up a fibril are aligned in
register.
The average length of fibrils, 𝐿(𝑡), was computed by solving
Eq. (8) together with Eqs. (17) and (18). The comparison
of 𝑀(𝑡) and 𝐿(𝑡) with the 𝛽-LAC mass and length mea-
surements in Fig. 6 shows agreement between theory and
experiment. The solid black curves in Fig. 6 represent the
theoretical prediction for the case where all ThT data points
were used, while the dashed blue curves represent the theo-
retical fit where only ThT data points up to 25 hours were
used. In Fig. 7, the theoretical results are compared with the
length distribution of the fibrils in the AFM experiment at
various times. The theoretical distribution used to compare
with the results in Fig. 7 was 𝑃𝑟(𝑡) = 𝑐𝑟(𝑡)/
∑︀∞
𝑟=𝑛𝑐
2𝑐𝑟(𝑡)
where the factor of two was introduced because we assumed
that each fibril contained two filaments. In addition to the
adjustable constants 𝑘𝑃 , 𝑘𝑀 , and 𝑘𝑛, the fractal dimension
𝐷𝑓 was found to be 𝐷𝑓 ≈ 1.35. As reported earlier, fractal
dimensions for other non-amyloid protein aggregates have
been found to be 𝐷𝑓 ≈ 2.0 − 2.7 [64, 73, 74]. For amyloid
fibrils, the aggregates are long, and rod-like in shape, thus
we might expect that 𝐷𝑓 ∼ 1.
Arosio et al. [41], and others[9], have showed that a model
similar to the one used by Knowles et al. [36] needs an
FIG. 7. Predicted length distributions at 5, 8, 16, and 48 hours.
In each plot, the shaded columns represent the AFM data with
histogram bin widths of 10 nm, while the solid black curves
represents the theoretical predictions. The parameters used were
those that correspond with the solid black curve in Fig. 6.
adjustment to the constant fragmentation rates to fit the
same data for 𝛽-LAC fibrils. If the rate of breaking, 𝑘−, like in
Eq. (9), is assumed to possess a size dependence ∼ 𝑟𝜆, where
𝑟 is the size of the aggregate, then using 𝜆 = 3 allows Arosio’s
model accurately predict the average lengths of the fibrils. We
have shown that the aggregation and fragmentation kernels
derived from diffusion theory can accurately predict the ThT
and AFM data for the 𝛽-LAC fibrils.
9V. GENERALIZED KINETICS
Now, we return to the scenario where oligomers may reach
metastable states before becoming fibrils. As discussed in
the section “Critical Nuclei”, some of the small micelle-like
aggregates could undergo a conformational transition to B-
type nuclei when their sizes reach the critical nucleus. B-type
aggregates could then grow into fibrils that could be long and
contain large amounts of 𝛽-structure. Since both A-type and
B-type aggregates are kinetically active at the same time,
they may compete for available monomers [75] in order to
grow larger. A more general scenario, where small micelle-
like aggregates containing 𝑛𝑐 number of proteins may form,
is described by the reactions
𝐶1 + 𝐶1
𝑘𝐴+

𝑘𝐴−
𝐶𝐴2 (22)
𝐶1 + 𝐶
𝐴
2
𝑘𝐴+

𝑘𝐴−
𝐶𝐴3
...
𝐶1 + 𝐶
𝐴
𝑛𝑐−1
𝑘𝐴+

𝑘𝐴−
𝐶𝐴𝑛𝑐
where 𝑘𝐴+ is the monomer addition rate constant, and 𝑘
𝐴
−
is the monomer subtraction rate constant. For simplicity it
was assumed that all forward rates have the same value, and
likewise for the backwards rates.
The mass-action equations governing the evolution of the
concentrations for 𝐴 and 𝐵 types can be written using Becker-
Do¨ring or Smoluchowski kinetics. For example, using the
Smoluchowski kinetics for the A- and B-type aggregates, the
mass-action equations governing the kinetics can be written
as
𝑑𝑐𝐴𝑟 (𝑡)
𝑑𝑡
= 𝑊𝐴𝑟−1,1(𝑡)−𝑊𝐴𝑟,1(𝑡)− 𝑘𝑛𝑐𝐴𝑛𝑐(𝑡)𝛿𝑟,𝑛𝑐 (23)
𝑑𝑐𝐵𝑟 (𝑡)
𝑑𝑡
=
1
2
𝑟−1∑︁
𝑠=1
𝑊𝐵𝑠,𝑟−𝑠(𝑡)−
∞∑︁
𝑠=1
𝑊𝐵𝑟,𝑠(𝑡)
+ 𝑘𝑛𝑐
𝐴
𝑛𝑐(𝑡)𝛿𝑟,𝑛𝑐 (24)
𝑑𝑐1(𝑡)
𝑑𝑡
= −
𝑛𝑐∑︁
𝑟=2
𝑟
𝑑𝑐𝐴𝑟 (𝑡)
𝑑𝑡
−
∞∑︁
𝑟=𝑛𝑐
𝑟
𝑑𝑐𝐵𝑟 (𝑡)
𝑑𝑡
(25)
where the fluxes 𝑊𝑟,𝑠 were defined in Eq. (7) and we assumed
that the A-type aggregates cannot grow larger than the
critical size 𝑛𝑐. B-type aggregates must be at least the
size of the critical nucleus. The third term in Eqs. (23)
and (24) represents the loss of A-type and the gain of B-
type aggregates of size 𝑛𝑐, respectively. No longer is the
nucleus production term in Eq. (24) simply proportional
to the monomer concentration raised to the power 𝑛𝑐, as
it was in Eq. (5) when we assumed the A-type micelles
rapidly reached equilibrium. Eqs. (23-25) are easily solved
numerically.
An example calculation of the mass in aggregates is shown
in Fig. 8 based on Eq. (9) with Eqs. (23) and (25). The A-
type oligomers may grow to the size of the critical nucleus, 𝑛𝑐,
FIG. 8. Predicted masses of 𝐴 (solid blue line) and 𝐵 (dashed
black line) type aggregates. Monomers are also plotted (dashed-
dotted red line). The concentrations of 𝐵-type aggregates were
determined using Knowles’ model, i.e. Eq. (9). Green circles are
the selected FlAsH fluorescence data points from Lee et al. [27].
The 𝐴-type oligomer for A𝛽(1-40) was assumed to be a dimer. The
𝐴-type oligomers may then undergo a conformational transition to
𝐵-type critical nuclei. 𝐵-type critical nuclei may proceed to grow
into amyloid fibrils. Parameters used in the fit were𝑚𝑡𝑜𝑡 = 10 𝜇M,
𝑘𝐴+ = 269 M
−1 s−1, 𝑘𝐴− = 0.00015 s
−1, 𝑘𝐵+ = 1.3 · 104 M−1 s−1,
𝑘𝐵− = 3.87 · 10−6 s−1, 𝑘𝑛 = 2.64 · 10−6 M−1 s−1.
and convert into sheet, or shrink by monomer subtraction.
The plot clearly shows an oligomer phase, followed by a
transition phase where the oligomers either dissociate, or
convert to 𝐵-type nuclei. Eventually, the aggregates mostly
become 𝐵-type fibrils. These results should be compared
with the experimental results obtained by Lee et al. [27],
which show similar FlAsH ThT florescence curves for the
masses in oligomers and fibrils. Additionally, the curves in
Fig. 8 seem to agree with the theoretical results obtained by
Lee [30].
VI. DISCUSSION AND CONCLUSION
In this article, we studied the kinetics of protein aggre-
gation using several mass-action models that describe the
evolution of aggregate concentrations 𝑐𝑟(𝑡). The NP and
Knowles’ models have been well-studied in the literature.
However, the Smoluchowski model for protein aggregation
has received very little attention. Knowles’ model, and our
proposed Smoluchowski model for protein aggregation, both
have been shown to fit ThT curves reliably, where each model
has the feature that aggregate breaking can act as a feedback
loop, where the fragments can act as seeds, and could range
in size from the critical nucleus, or larger. However, when
turning attention to the model predictions for the length
distribution of aggregates, 𝐿(𝑡), the models predict very
different results when compared to each other.
The average lengths of aggregates in the Smoluchowski
and Knowles models both exhibit a maximum average length
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at some time 𝑡, which then decreases at later times. The
Smoluchowski model predicts that the aggregates will shrink
down in size at later times, but not nearly as quickly as those
aggregates described by Knowles’ model. Thus, the average
aggregate size described by the Smoluchowski model with
constant kernels is found to be larger than that predicted by
Knowles’ model. But more importantly, kinetic models with
constant kernels cannot be made to fit the length distribution
data obtained for 𝛽-LAC fibrils using AFM. On the other
hand, we show that by introducing length-dependent kernels
to the Smoluchowski model yields results in good agreement
with experimental data.
Additionally, we also show that a kinetics model that
allows for oligomer concentrations of aggregates smaller than
𝑛𝑐 can describe the conformational conversation of a micelle
to a more ordered nucleus, which may then grow into fibrils.
The theoretical results obtained seem to agree qualitatively
with the recent FlAsH fluorescence results obtained by Lee
et al. [27] in which a metastable oligomer phase seems to
precede the elongation of fibrils.
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